RMD Q1 2023 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q1 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$950M+5.1% YoY

Gross Profit

$541M56.9% margin

Operating Income

$276M29.0% margin

Net Income

$210M22.1% margin

EPS (Diluted)

$1.43

QoQ Revenue Growth

+3.9%

Cash Flow

Operating Cash Flow

$45M

Free Cash Flow

$12M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$5.2B

Total Liabilities

$1.7B

Stockholders' Equity

$3.4B

Cash & Equivalents

$207M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$950M	$904M	+5.1%
Gross Profit	$541M	$506M	+6.8%
Operating Income	$276M	$262M	+5.3%
Net Income	$210M	$204M	+3.4%

Revenue Segments

Sleep And Respiratory

$844M89%

Software As Service

$106M11%

Geographic Segments

Us Canada And Latin America

$684M72%

Combined Europe Asia And Other Markets

$266M28%